These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2252334)
1. Serotonin agents in anxiety. Taylor DP Ann N Y Acad Sci; 1990; 600():545-56; discussion 556-7. PubMed ID: 2252334 [TBL] [Abstract][Full Text] [Related]
2. Buspirone, a new approach to the treatment of anxiety. Taylor DP FASEB J; 1988 Jun; 2(9):2445-52. PubMed ID: 2836252 [TBL] [Abstract][Full Text] [Related]
3. Buspirone and related compounds as alternative anxiolytics. Taylor DP; Moon SL Neuropeptides; 1991 Jul; 19 Suppl():15-9. PubMed ID: 1679210 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of generalized anxiety: new pharmacologic approaches]. Boulenger JP Encephale; 1995; 21(6):459-66. PubMed ID: 8674471 [TBL] [Abstract][Full Text] [Related]
8. [Central serotonin receptors. Principal fundamental and functional aspects. Therapeutic applications]. Moulignier A Rev Neurol (Paris); 1994; 150(1):3-15. PubMed ID: 7801037 [TBL] [Abstract][Full Text] [Related]
9. Use of animal models: toward anxioselective drugs. Eison MS Psychopathology; 1984; 17 Suppl 1():37-44. PubMed ID: 6143343 [TBL] [Abstract][Full Text] [Related]
10. Activity of Serotonin 5-HT Jastrzębska-Więsek M; Partyka A; Rychtyk J; Śniecikowska J; Kołaczkowski M; Wesołowska A; Varney MA; Newman-Tancredi A ACS Chem Neurosci; 2018 May; 9(5):1040-1050. PubMed ID: 29266914 [TBL] [Abstract][Full Text] [Related]
11. New anxiolytics in development. Mosconi M; Chiamulera C; Recchia G Int J Clin Pharmacol Res; 1993; 13(6):331-44. PubMed ID: 7916335 [TBL] [Abstract][Full Text] [Related]
12. Impact of anxiety therapy on patients' quality of life. Feighner JP Am J Med; 1987 May; 82(5A):14-9. PubMed ID: 2884872 [TBL] [Abstract][Full Text] [Related]
13. Translational Studies in the Complex Role of Neurotransmitter Systems in Anxiety and Anxiety Disorders. Olivier JDA; Olivier B Adv Exp Med Biol; 2020; 1191():121-140. PubMed ID: 32002926 [TBL] [Abstract][Full Text] [Related]
14. Serotonergic anxiolytics and treatment of depression. Robinson DS; Alms DR; Shrotriya RC; Messina M; Wickramaratne P Psychopathology; 1989; 22 Suppl 1():27-36. PubMed ID: 2657837 [TBL] [Abstract][Full Text] [Related]
16. A clinical trial of buspirone and diazepam in the treatment of generalized anxiety disorder. Ross CA; Matas M Can J Psychiatry; 1987 Jun; 32(5):351-5. PubMed ID: 3308052 [TBL] [Abstract][Full Text] [Related]
17. [Buspirone in the treatment of Generalized Anxiety Disorders]. Rzewuska M; Sobucka K Psychiatr Pol; 1993; 27(5):545-61. PubMed ID: 8255947 [TBL] [Abstract][Full Text] [Related]
18. Future directions in anxiolytic pharmacotherapy. Kunovac JL; Stahl SM Psychiatr Clin North Am; 1995 Dec; 18(4):895-909. PubMed ID: 8748388 [TBL] [Abstract][Full Text] [Related]
19. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Griebel G Pharmacol Ther; 1995 Mar; 65(3):319-95. PubMed ID: 7644567 [TBL] [Abstract][Full Text] [Related]
20. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam. Moser PC; Tricklebank MD; Middlemiss DN; Mir AK; Hibert MF; Fozard JR Br J Pharmacol; 1990 Feb; 99(2):343-9. PubMed ID: 1970269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]